Due to the minimal signs of anti-tumor activity (10.3% of participants had transient PSA decreases, including only 1 confirmed PSA50 response; 3 participants had partial response by PCWG3 criteria in the context of rapidly rising PSA) and high incidence of CRS, the study was terminated. This evidence concerns the gene KLK3 and congenital rubella syndrome.